文传商讯

European Commission approves SPEVIGO (spesolimab) for generalized pustular psoriasis flares
2022-12-16 09:14:20

Reduced-risk* Potential of Velo as Cigarette Alternative Reinforced by Innovative Real-world Study
2022-12-16 09:14:20

MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program
2022-12-16 09:14:20

JT Included in the Dow Jones Sustainability Asia Pacific Index for the Ninth Consecutive Year
2022-12-16 09:14:20